Rankings
▼
Calendar
NAGE Q4 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$393M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$9M
+20.4% YoY
Gross Profit
$5M
52.0% margin
Operating Income
-$8M
-90.9% margin
Net Income
-$8M
-90.6% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
+11.7%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$42M
Total Liabilities
$15M
Stockholders' Equity
$27M
Cash & Equivalents
$22M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$9M
$8M
+20.4%
Gross Profit
$5M
$4M
+22.8%
Operating Income
-$8M
-$9M
+6.1%
Net Income
-$8M
-$9M
+6.8%
← FY 2018
All Quarters
Q1 2019 →